There is no treatment or vaccine for Ebola.

During the 2014-2016 outbreak in West Africa, more than 11,000 people were killed. Outbreaks continue to flare up in the region.

The Boston University National Emerging Infectious Diseases laboratory on Albany Steet, the so-called "Biolab", recieved it's first sample of the Ebola virus for research purposes last week.

The lab is classified at Biosafety Level 4. Accoding to the lab, there are "special engineering and design features to prevent microorganisms from being disseminated into the environment."

In December, 2017 The Boston Public Health Commission granted final approval for the laboratory to start research on the world's deadliest microbes. This after nearly 15 years of controversy.

"These people are gambling with our safety and we don't have a say," James Alan Fox, president of the Union Park neighborhood association told the Boston Herald.

Mayor Martin J. Walsh said in a statement, "The safety of Boston residents is our top priority, and the Boston Public Health Commission has ensured the laboratory has met the strictest safety procedures and will continue to monitor and inspect the lab to ensure it continues to meet all health and safety requirements."